An overview of microneedle applications, materials, and fabrication methods

Abstract

Microneedle-based microdevices promise to expand the scope for delivery of vaccines and therapeutic agents through the skin and withdrawing biofluids for point-of-care diagnostics – so-called theranostics. Unskilled and painless applications of microneedle patches for blood collection or drug delivery are two of the advantages of microneedle arrays over hypodermic needles. Developing the necessary microneedle fabrication processes has the potential to dramatically impact the health care delivery system by changing the landscape of fluid sampling and subcutaneous drug delivery. Microneedle designs which range from sub-micron to millimetre feature sizes are fabricated using the tools of the microelectronics industry from metals, silicon, and polymers. Various types of subtractive and additive manufacturing processes have been used to manufacture microneedles, but the development of microneedle-based systems using conventional subtractive methods has been constrained by the limitations and high cost of microfabrication technology. Additive manufacturing processes such as 3D printing and two-photon polymerization fabrication are promising transformative technologies developed in recent years. The present article provides an overview of microneedle systems applications, designs, material selection, and manufacturing methods.

References 109

1. 1.

   Gerstel M S, Place V A. Drug Delivery Device. U.S. Patent. 1976.

   Not in our library

2. 2.

   Li Y, Zhang H, Yang R, Tazrin F, Zhu C, Kaddoura M, Blondeel E J M, Cui B. Sens Actuators, A. 2019;292:149-157.

   Not in our library10.1016/j.sna.2019.04.008

3. 3.

   Wang J, Wang H, Lai L, Li Y. Micromachines. 2020;12(1):23.

   Not in our library10.3390/mi12010023

4. 4.

   Li J, Zhou Y, Yang J, Ye R, Gao J, Ren L, Liu B, Liang L, Jiang L. Mater Sci Eng, C. 2019;96:576-582.

   Not in our library10.1016/j.msec.2018.11.074

5. 5.

   Faraji Rad Z, Nordon R E, Anthony C J, Bilston L, Prewett P D, Arns J-Y, Arns C H, Zhang L, Davies G J. Microsyst Nanoeng. 2017;3:17034.

   Not in our library10.1038/micronano.2017.34

6. 6.

   Jiang J, Gill H S, Ghate D, McCarey B E, Patel S R, Edelhauser H F, Prausnitz M R. Invest Ophthalmol Visual Sci. 2007;48:4038-4043.

   Not in our library10.1167/iovs.07-0066

7. 7.

   Yum K, Wang N, Yu M-F. Nanoscale. 2010;2:363-372.

   Not in our library10.1039/b9nr00231f

8. 8.

   Yum K, Yu M-F, Wang N, Xiang Y K. Biochim Biophys Acta, Gen Subj. 2011;1810:330-338.

   Not in our library10.1016/j.bbagen.2010.05.005

9. 9.

   Gill H S, Denson D D, Burris B A, Prausnitz M R. Clin J Pain. 2008;24:585-594.

   Not in our library10.1097/ajp.0b013e31816778f9

10. 10.

    Gupta J, Park S S, Bondy B, Felner E I, Prausnitz M R. Biomaterials. 2011;32:6823-6831.

    Not in our library10.1016/j.biomaterials.2011.05.061

11. 11.

    Singh R, Singh S, Lillard J W. J Pharm Sci. 2008;97:2497-2523.

    Not in our library10.1002/jps.21183

12. 12.

    Vrdoljak A. Vaccine: Dev Ther. 2013;3:47-55.

    Not in our library10.2147/vdt.s34682

13. 13.
    Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development · 2020

    No notice
14. 14.

    Courtenay A J, McCrudden M T C, McAvoy K J, McCarthy H O, Donnelly R F. Mol Pharmaceutics. 2018;15:3545-3556.

    Not in our library10.1021/acs.molpharmaceut.8b00544

15. 15.

    Mir M, Permana A D, Ahmed N, Khan G M, Rehman A u, Donnelly R F. Eur J Pharm Biopharm. 2020;147:57-68.

    Not in our library10.1016/j.ejpb.2019.12.008

16. 16.
    Microneedle-Based Delivery: An Overview of Current Applications and Trends · 2020

    No notice
17. 17.
    Hydrogel‐Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery · 2012

    No notice
18. 18.

    Turner J G, White L R, Estrela P, Leese H S. Macromol Biosci. 2021;21:2000307.

    Not in our library10.1002/mabi.202000307

19. 19.

    Kis E E, Winter G, Myschik J. Vaccine. 2012;30(3):523-538.

    Not in our library10.1016/j.vaccine.2011.11.020

20. 20.

    Kim Y-C, Park J-H, Prausnitz M R. Adv Drug Delivery Rev. 2012;64:1547-1568.

    Not in our library10.1016/j.addr.2012.04.005

21. 21.

    Kang S-M, Song J-M, Kim Y-C. Expert Rev Vaccines. 2012;11:547-560.

    Not in our library10.1586/erv.12.25

22. 22.

    Kim Y-C, Quan F-S, Compans R W, Kang S-M, Prausnitz M R. J Controlled Release. 2010;142:187-195.

    Not in our library10.1016/j.jconrel.2009.10.013

23. 23.

    Yan K, Todo H, Sugibayashi K. Int J Pharm. 2010;397:77-83.

    Not in our library10.1016/j.ijpharm.2010.06.052

24. 24.

    Donnelly R F, Majithiya R, Singh T R R, Morrow D I J, Garland M J, Demir Y K, Migalska K, Ryan E, Gillen D, Scott C J, et al. Pharm Res. 2011;28(1):41-57.

    Not in our library10.1007/s11095-010-0169-8

25. 25.

    van der Maaden K, Sekerdag E, Schipper P, Kersten G, Jiskoot W, Bouwstra J. Langmuir. 2015;31:8654-8660.

    Not in our library10.1021/acs.langmuir.5b01262

26. 26.

    Mikszta J A, Dekker J P, Harvey N G, Dean C H, Brittingham J M, Huang J, Sullivan V J, Dyas B, Roy C J, Ulrich R G. Infect Immun. 2006;74:6806-6810.

    Not in our library10.1128/iai.01210-06

27. 27.

    Requena M B, Permana A D, Vollet‐Filho J D, González‐Vázquez P, Garcia M R, De Faria C M G, Pratavieira S, Donnelly R F, Bagnato V S. J Biophotonics. 2021;14(1):e202000128.

    Not in our library10.1002/jbio.202000128

28. 28.

    Oh J-H, Park H-H, Do K-Y, Han M, Hyun D-H, Kim C-G, Kim C-H, Lee S S, Hwang S-J, Shin S-C, et al. Eur J Pharm Biopharm. 2008;69:1040-1045.

    Not in our library10.1016/j.ejpb.2008.02.009

29. 29.

    Peters E E, Ameri M, Wang X, Maa Y-F, Daddona P E. Pharm Res. 2012;29(6):1618-1626.

    Not in our library10.1007/s11095-012-0674-z

30. 30.

    Demir Y K, Akan Z, Kerimoglu O. PLoS One. 2013;8:e63819.

    Not in our library10.1371/journal.pone.0063819

31. 31.

    Han T, Das D B. J Pharm Sci. 2013;102:3614-3622.

    Not in our library10.1002/jps.23662

32. 32.

    van der Maaden K, Varypataki E M, Romeijn S, Ossendorp F, Jiskoot W, Bouwstra J. Eur J Pharm Biopharm. 2014;88:310-315.

    Not in our library10.1016/j.ejpb.2014.05.003

33. 33.

    Ma Y, Li C G, Kim S, Fakhraei Lahiji S, Lee C, Jung H. Adv Mater Technol (Weinheim, Ger). 2018;3(12):1800234.

    Not in our library10.1002/admt.201800234

34. 34.

    Lee I-C, Lin W-M, Shu J-C, Tsai S-W, Chen C-H, Tsai M-T. J Biomed Mater Res, Part A. 2017;105(1):84-93.

    Not in our library10.1002/jbm.a.35869

35. 35.

    Pearton M, Saller V, Coulman S A, Gateley C, Anstey A V, Zarnitsyn V, Birchall J C. J Controlled Release. 2012;160:561-569.

    Not in our library10.1016/j.jconrel.2012.04.005

36. 36.

    Donnelly R F, Morrow D I J, Singh T R R, Migalska K, McCarron P A, O'Mahony C, Woolfson A D. Drug Dev Ind Pharm. 2009;35:1242-1254.

    Not in our library10.1080/03639040902882280

37. 37.

    Lee J W, Park J-H, Prausnitz M R. Biomaterials. 2008;29(13):2113-2124.

    Not in our library10.1016/j.biomaterials.2007.12.048

38. 38.

    Gittard S D, Chen B, Xu H, Ovsianikov A, Chichkov B N, Monteiro-Riviere N A, Narayan R J. J Adhes Sci Technol. 2013;27:227-243.

    Not in our library10.1080/01694243.2012.705101

39. 39.

    Haidary S M, Córcoles E P, Ali N K. J Nanomater. 2012;830503.

    Not in our library10.1155/2012/830503

40. 40.

    Ksenofontova O I, Vasin A V, Egorov V V, Bobyl’ A V, Soldatenkov F Y, Terukov E I, Ulin V P, Ulin N V, Kiselev O I. Tech Phys. 2014;59:66-77.

    Not in our library10.1134/s1063784214010083

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.